Clozaril (clozapine)
Executive Summary
Sandoz begins distribution of the antipsychotic drug to patients whose doctors have enrolled them in a mandatory patient management system. FDA approved Clozaril as a 1A drug in 1989, for treatment of severely ill schizophrenic patients who fail to respond to standard drug therapies. Availability of the drug follows a four-month education campaign for health care professionals.